Distinct actions of Akt1 on skeletal architecture and function

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Mukherjee, Aditi ^a   Larson, Emily A ^b   Klein, Robert F ^a,b   Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; AKT1 PROTEIN, MOUSE; AKT2 PROTEIN, MOUSE;

ADULT; AKT1 GENE; AKT2 GENE; ANIMAL CELL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE GROWTH; BONE MASS; BONE MATURATION; BONE STRENGTH; BONE STRUCTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); ENZYME DEFICIENCY; FEMALE; FEMUR; GENE; GENE FUNCTION; GENE LOSS; MALE; MOUSE; MUSCULOSKELETAL FUNCTION; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; STEM CELL; TRABECULAR BONE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE DENSITY; CELL DIFFERENTIATION; FEMALE; FEMUR; MALE; MICE; MICE, MUTANT STRAINS; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84899766060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093040     Document Type: Article

References (50)

1. Feng X, McDonald JM (2011) Disorders of bone remodeling. Annu Rev Pathol 6: 121-145.
2. Henriksen K, Bollerslev J, Everts V, Karsdal MA (2011) Osteoclast activity and subtypes as a function of physiology and pathology - implications for future treatments of osteoporosis. Endocr Rev 32: 31-63.
3. Zaidi M (2007) Skeletal remodeling in health and disease. Nature Medicine 13: 791-801.
4. Novack DV, Teitelbaum SL (2008) The osteoclast: friend or foe? Annu Rev Pathol 3: 457-484. (Pubitemid 351488289)
5. Raggatt LJ, Partridge NC (2011) Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285: 25103-25108.
6. Karaguzel G, Holick MF (2011) Diagnosis and treatment of osteopenia. Rev Endocr Metab Disord 11: 237-251.
7. Khosla S, Melton LJ 3rd (2007) Clinical practice. Osteopenia. N Engl J Med 356: 2293-2300.
8. Ferrari S (2008) Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab 22: 723-735.
9. Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, et al. (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41: 1199-1206.
10. Klein RF (2008) Genetics of osteoporosis - utility of mouse models. J Musculoskelet Neuronal Interact 8: 287-290.
11. Xiong Q, Jiao Y, Hasty KA, Canale ST, Stuart JM, et al. (2009) Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse. Genomics 93: 401-414.
12. Xu XH, Dong SS, Guo Y, Yang TL, Lei SF, et al. (2010) Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocr Rev 31: 447-505.
13. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, et al. (2002) Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277: 33361-33368. (Pubitemid 34984859)
14. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, et al. (2007) Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci USA 104: 2259-2264. (Pubitemid 46391385)
15. McGonnell IM, Grigoriadis AE, Lam EW, Price JS, Sunters A (2012) A specific role for phosphoinositide 3-kinase and AKT in osteoblasts? Front Endocrinol (Lausanne) 3: 88.
16. Osyczka AM, Leboy PS (2005) Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146: 3428-3437. (Pubitemid 41058115)
17. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365. (Pubitemid 36666005)
18. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274. (Pubitemid 46962095)
19. Mukherjee A, Rotwein P (2009) Akt promotes BMP2-mediated osteoblast differentiation and bone development. J Cell Sci 122: 716-726.
20. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39. (Pubitemid 28458022)
21. Sun H, Lesche R, Li DM, Liliental J, Zhang H, et al. (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A 96: 6199-6204. (Pubitemid 29256643)
22. Liu H, Radisky DC, Nelson CM, Zhang H, Fata JE, et al. (2006) Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci U S A 103: 4134-4139.
23. Mukherjee A, Wilson EM, Rotwein P (2008) Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol Endocrinol 22: 206-215.
24. Mukherjee A, Larson EA, Carlos AS, Belknap JK, Rotwein P, et al. (2012) Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor beta1-mediated signaling and bone acquisition. J Bone Miner Res 27: 1345-1356.
25. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, et al. (2010) Guidelines for assessment of bone microstructure in rodents using microcomputed tomography. J Bone Miner Res 25: 1468-1486.
26. Soleimani M, Nadri S (2009) A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4: 102-106.
27. Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, et al. (2000) Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 275: 27307-27310.
28. Mukherjee A, Rotwein P (2008) Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol Endocrinol 22: 1238-1250. (Pubitemid 351629622)
29. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ (2001) Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352.
30. Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, et al. (2007) Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One 2: e1058.
31. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, et al. (2003) Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278: 32124-32131. (Pubitemid 37048402)
32. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731. (Pubitemid 32506248)
33. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, et al. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112: 197-208. (Pubitemid 38056356)
34. Atanur SS, Diaz AG, Maratou K, Sarkis A, Rotival M, et al. (2013) Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell 154: 691-703.
35. Patil CK, McCarroll SA (2013) Of rats and men. Cell 154: 481-483.
36. Brandi ML (2009) Microarchitecture, the key to bone quality. Rheumatology (Oxford) 48 Suppl 4: iv3-8.
37. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M (2013) Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 280: 4294-4314.
38. Toker A (2011) Achieving specificity in Akt signaling in cancer. Adv Biol Regul 52: 78-87.
39. Toker A, Yoeli-Lerner M (2006) Akt signaling and cancer: surviving but not moving on. Cancer Res 66: 3963-3966.
40. Tzivion G, Hay N (2011) PI3K-AKT-FoxO axis in cancer and aging. Biochim Biophys Acta 1813: 1925.
41. Dummler B, Tschopp O, Hynx D, Yang ZZ, Dirnhofer S, et al. (2006) Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 26: 8042-8051. (Pubitemid 44631003)
42. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, et al. (2005) Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25: 1869-1878. (Pubitemid 40280150)
43. Somerville JM, Aspden RM, Armour KE, Armour KJ, Reid DM (2004) Growth of C57BL/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int 74: 469-475. (Pubitemid 38623633)
44. Manolagas SC, O'Brien CA, Almeida M (2013) The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol 9: 699-712.
45. Ohlsson C, Borjesson AE, Vandenput L (2012) Sex steroids and bone health in men. Bonekey Rep 1: 2.
46. Oury FA (2012) Crosstalk between bone and gonads. Ann NY Acad Sci 1260: 1-7.
47. Nakae J, Kido Y, Accili D (2001) Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22: 818-835. (Pubitemid 34214297)
48. Sugatani T, Hruska KA (2005) Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583-3589. (Pubitemid 40223824)
49. Tu Q, Zhang J, Dong LQ, Saunders E, Luo E, et al. (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem 286: 12542-12553.
50. Mukherjee A, Rotwein P (2012) Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mol Cell Biol 32: 490-500.